Harbour BioMed

Harbour BioMed is an operating biopharmaceutical company with strategic investment relevance for life sciences startups seeking capital, clinical-development expertise or partnership alignment. Its focus includes biotechnology, pharmaceuticals, antibody therapeutics, oncology and adjacent AI and machine learning applications, and its investment geography is global, including Greater China, the United States, Europe and Switzerland.